Cargando…
Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes
Diabetes mellitus (DM) is a major chronic disease with ever‐increasing prevalence and a variety of serious complications for persons with DM, such as cardiovascular and/or renal complications. New glucose‐lowering therapies like DPP‐4 inhibitors, GLP‐1 receptor agonists, and SGLT‐2 inhibitors have u...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375088/ https://www.ncbi.nlm.nih.gov/pubmed/32704554 http://dx.doi.org/10.1002/edm2.129 |